# 119-hr-8269: CLEAR LABELS Act

119-hr-8269, CLEAR LABELS Act, is a 119th Congress bill sponsored by Rep. McCormick, Richard [R-GA-7] (R-GA); status introduced; PRIA reads it as touching household money (as of 2026-09-21).

- Canonical: https://policyrisk.com/legislation/119-hr-8269
- As of: 2026-09-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-8269
- Congress: 119
- Title: CLEAR LABELS Act
- Status: introduced
- Introduced: 2026-04-14
- Sponsor: Rep. McCormick, Richard [R-GA-7] (R-GA)
- Cosponsors: 2
- Policy area: Commerce
- Touches household money: yes
- Last recorded action: 2026-09-21

## Summary

**This bill would require drug labels and related certificates to disclose the product's **original manufacturer and key supply‑chain details** for finished drugs and active pharmaceutical ingredients.** It would let that information appear directly on packaging or through a link, barcode, QR code, or other access to a searchable electronic portal. - Patients and caregivers could access who made a medicine and where it came from via label text or a linked portal. This includes packer or distributor info and quantity statements for packaged drugs. - Drug manufacturers, packers, and distributors would have to list the original manufacturer of the finished product and each active pharmaceutical ingredient. They must make the data available electronically and provide paper copies or package inserts on request. - Suppliers of active pharmaceutical ingredients must include the original manufacturer's name, place of business, and a unique facility identifier on labels and certificates of analysis. - The Health Secretary would write implementing regulations, may allow reasonable variations or electronic placements, and set an effective date at least one year after final rules take effect. The bill also exempts certain finished drug markings from specified Tariff Act marking rules when labeled under the Federal Food, Drug, and Cosmetic Act.

## Cosponsors (2)

- Rep. DeLauro, Rosa L. [D-CT-3] (D-CT), 2026-04-14T00:00:00.000Z
- Rep. Fuller, Clay [R-GA-14] (R-GA), 2026-06-03T00:00:00.000Z

## Provisions PRIA read

- New drug labels list manufacturers: benefit, high. This bill would require finished drug product labels to identify the original maker of each active ingredient and the finished drug maker. Labels must show name, place of business, and a facility identifier, or provide a link, barcode, QR code, or other access to a searchable portal with that infor…
- Tariff marking exemption for drugs: benefit, medium. The bill would add an exemption so finished drug products that are marked under the new drug-labeling rules would not have to follow the general country-of-origin marking requirements in the Tariff Act. The exemption would only apply to finished drug products that meet the bill's labeling standard.

## Related bills

- 119-hr-3151: SHIPS for America Act of 2025
- 119-hr-5450: Continuing Appropriations and Extensions and Other Matters Act, 2026
- 119-hr-3277: Ensuring Lasting Smiles Act
- 119-hr-6900: American Affordability Act of 2025
- 119-hr-5089: Weather Act Reauthorization Act of 2025
- 119-hr-137: TCJA Permanency Act

## Sources
- [119-hr-8269 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/8269)

## Related
- [119-hr-3151: SHIPS for America Act of 2025](https://policyrisk.com/legislation/119-hr-3151)
- [119-hr-5450: Continuing Appropriations and Extensions and Other Matters Act, 2026](https://policyrisk.com/legislation/119-hr-5450)
- [119-hr-3277: Ensuring Lasting Smiles Act](https://policyrisk.com/legislation/119-hr-3277)
- [119-hr-6900: American Affordability Act of 2025](https://policyrisk.com/legislation/119-hr-6900)
- [119-hr-5089: Weather Act Reauthorization Act of 2025](https://policyrisk.com/legislation/119-hr-5089)
- [119-hr-137: TCJA Permanency Act](https://policyrisk.com/legislation/119-hr-137)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-8269 (as of 2026-09-21).